Aeromonas spp.: An Emerging Nosocomial Pathogen

• Published in: Journal of laboratory physicians Vol. 8; no. 1; pp. 001 - 004
• Main Authors: Batra, Priyam, Mathur, Purva, Misra, Mahesh C
• Format: Journal Article
• Language: English
• Published: A-12, Second Floor, Sector -2, NOIDA -201301, India Thieme Medical and Scientific Publishers Private Ltd 01.01.2016; Wolters Kluwer - Medknow Publications; Medknow Publications and Media Pvt. Ltd; Thieme Medical Publishers Inc; Medknow Publications & Media Pvt Ltd; Thieme Medical and Scientific Publishers Pvt. Ltd
• Subjects: Aeromonas; Antibiotics; Biofilms; Causes of; Conflicts of interest; Cross infection; Diarrhea; Ear diseases; emerging pathogen; Fish; Health aspects; immunocompetent; Infections; Meningitis; Review; Review Article; Sewage disposal; Urinary tract diseases; Urogenital system; immunocompetent; Aeromonas; emerging pathogen
• ISSN: 0974-2727; 0974-7826
• DOI: 10.4103/0974-2727.176234

ABSTRACT Aeromonads are hallophillic, nonacid fast, nonspore forming, Gram-negative rods which are widely distributed in the soil, foodstuffs, and aquatic environment. Since times immemorial, they are important zoonotic pathogens of poikilotherms but are now emerging as important human pathogens. These emerging enteric pathogens flourish in the water distribution system by forming biofilms. They possess large number of virulence factors including inherent resistance to various antibiotics and ability to form biofilms using quorum sensing. These properties make them easy pathogens for human infections. Aeromonads are important enteric pathogens, but, with the growing level of immunosuppression in the population, they have been associated with various extraintestinal infections, such as skin and soft‑tissue infections, traumatic wound infections, and lower respiratory tract/ urinary tract infections. The average annual incidence of bacteremia in Southern Taiwan due to Aeromonas spp. was 76 cases/ million inhabitants between 2008 and 2010. However, the incidence reported from Western countries is much lower. The case fatality rate among patients with Aeromonas bacteremia ranges from 27.5 to 46%. Aeromonads are universally resistant to the narrow-spectrum penicillin group of antibiotics such as penicillin, ampicillin, carbenicillin, and ticarcillin. They are however susceptible to piperacillin, azlocillin, second and third generation cephalosporins, and carbapenems. Most of the Aeromonas species are susceptible to aminoglycosides, tetracycline, chloramphenicol, trimethoprim‑sulfamethoxazole, quinolones, and monobactams. This manuscript is a comprehensive systematic review of the literature available on Aeromonas spp.